Medical Research

GLP-1 drugs linked to lower kidney failure risk in bipolar disorder featured image
Research
GLP-1 drugs linked to lower kidney failure risk in bipolar disorder

Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease.

Latest stories

Mayo Clinic Minute: Helping kids with anxiety through exposure therapy featured image
Health & Wellness
Mayo Clinic Minute: Helping kids with anxiety through exposure therapy
Deb Balzer
July 2, 2024
Drugs that kill “zombie” cells may benefit some older women, but not all, Mayo Clinic study finds featured image
Aging
Drugs that kill “zombie” cells may benefit some older women, but not all, Mayo Clinic study finds
Rhoda Madson
July 2, 2024
Innovation centers spur new biotherapeutics for patients featured image
Research
Innovation centers spur new biotherapeutics for patients
Susan Buckles
July 1, 2024
Training the next generation of clinical trial leaders featured image
Clinical Trials
Training the next generation of clinical trial leaders
Caitlin Doran
June 28, 2024
Reversing racism’s toll on heart health featured image
Translational Science
Reversing racism’s toll on heart health
Caitlin Doran
June 26, 2024
A Scientific Statement from the American Heart Association featured image
Individualized Medicine
A Scientific Statement from the American Heart Association
Colette Gallagher
June 21, 2024
Researchers identify vascular changes in the brain linked to Alzheimer’s disease featured image
Discovery Science
Researchers identify vascular changes in the brain linked to Alzheimer’s disease
Lynda De Widt
June 20, 2024
Physicians’ role crucial in using AI in patient care featured image
AI and Digital Health
Physicians’ role crucial in using AI in patient care
Vincent Jacobbi
June 19, 2024

Sign up to receive email notifications

Explore more topics

Sign up